Thu, June 9, 2022

Yigal Nochomovitz Maintained (ALDX) at Strong Buy with Increased Target to $26 on, Jun 9th, 2022

Yigal Nochomovitz of Citigroup, Maintained "Aldeyra Therapeutics, Inc." (ALDX) at Strong Buy with Increased Target from $21 to $26 on, Jun 9th, 2022.

Yigal has made no other calls on ALDX in the last 4 months.



There is 1 other peer that has a rating on ALDX. Out of the 1 peers that are also analyzing ALDX, 0 agree with Yigal's Rating of Hold.



This is the rating of the analyst that currently disagrees with Yigal


  • Andrew Fein of "HC Wainwright & Co." Initiated at Strong Buy and Held Target at $15 on, Wednesday, April 27th, 2022